![Fergal Hill](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Aktive Positionen von Fergal Hill
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Osivax SAS
![]() Osivax SAS BiotechnologyHealth Technology Osivax SAS engages in the development of infectious diseases vaccines and immunotherapies based on oligoDOM? proprietary technology. It operates in the influenza vaccine "INFLUENZA - OVX836" business segment. The company was founded by Alexandre Le Vert, Florence Nicolas and Fergal Hill on May 15, 2017 and is headquartered in Lyon, France. | Technik-/Wissenschafts-/F&E-Leiter | 15.05.2017 | - |
Gründer | 15.05.2017 | - |
Karriereverlauf von Fergal Hill
Ehemalige bekannte Positionen von Fergal Hill
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Imaxio SA
![]() Imaxio SA Medical SpecialtiesHealth Technology Imaxio SA develops biopharmaceutical products. It operates as a biotech company which focuses on vaccines, and based on the combination of commercial and research and development activities. The firm provides its services based on proprietary and Agilent DNA chips, notably CGH micro-array analyses. The company was founded by Christian Pradeyrol and Jean Chatellier in 2000 and is headquartered in Lyon, France. | Technik-/Wissenschafts-/F&E-Leiter | 18.01.2011 | - |
Statistik
International
Frankreich | 3 |
Operativ
Chief Tech/Sci/R&D Officer | 2 |
Founder | 1 |
Sektoral
Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Imaxio SA
![]() Imaxio SA Medical SpecialtiesHealth Technology Imaxio SA develops biopharmaceutical products. It operates as a biotech company which focuses on vaccines, and based on the combination of commercial and research and development activities. The firm provides its services based on proprietary and Agilent DNA chips, notably CGH micro-array analyses. The company was founded by Christian Pradeyrol and Jean Chatellier in 2000 and is headquartered in Lyon, France. | Health Technology |
Osivax SAS
![]() Osivax SAS BiotechnologyHealth Technology Osivax SAS engages in the development of infectious diseases vaccines and immunotherapies based on oligoDOM? proprietary technology. It operates in the influenza vaccine "INFLUENZA - OVX836" business segment. The company was founded by Alexandre Le Vert, Florence Nicolas and Fergal Hill on May 15, 2017 and is headquartered in Lyon, France. | Health Technology |
- Börse
- Insiders
- Fergal Hill
- Erfahrung